AKTX vs ETN · $17.2M cap vs P/E 39, rev $15.98B
Akari Therapeutics PLC (AKTX) versus Eaton Corporation PLC (ETN) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported ETN revenue for 2026-06-30 was $15.98B. Net income was $1.69B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
AKTX currently screens at market cap $17.2M. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Not investment advice. Open the AKTX and ETN stock pages for the full models.
Not investment advice.